Skin renewal and GHK-Cu

Procollagen in a reviewed skin study

A 2025 review of topical GHK describes increased procollagen synthesis in 70% of GHK-Cu-treated subjects, compared with 50% for vitamin C and 40% for retinoic acid. Procollagen is material used to make collagen, one of skin’s structural proteins. These percentages describe the share of subjects showing an increase. They give no percentage reduction in wrinkles.

The earlier skin-regeneration review also describes supporting-material production and small topical studies. The unglamorous work of maintaining that material deserves closer attention. A change in synthesis can be worth studying even while the size and durability of visible benefit need better human evidence.

GHK and GHK-Cu

GHK is a chain of three amino acids; GHK-Cu is that peptide holding copper. The distinction affects the chemistry and the interpretation of experiments. The skin-regeneration review discusses collagen and other supporting material made by cultured cells. Copper contributes to the repair-related activity described in this literature.

The gene-data review also considers changes in gene expression in cell-based and database work. Gene expression concerns how actively cells use genetic instructions. A grand rejuvenation story asks more than these cell-level changes can answer; I’d first ask which proteins and tissue functions change. Human whole-body effects still need direct investigation.

Copper crossing removed skin

The outer skin layer limits delivery. A study of removed human skin measured copper passage after application of the copper tripeptide and its retention within skin over 48 hours. It was an ex vivo experiment—skin studied outside the body.

Passage and retention are worthwhile measurements, and the topical-delivery review explains why permeability remains a central problem. Skin’s resistance to entry is the practical snag I’d investigate before entertaining a bigger benefit. Measuring copper on the other side leaves the clinical outcome to a different experiment.

Hair counts with a mixture

In a six-month trial involving forty-five men with androgenetic hair loss, a combination of GHK and 5-aminolevulinic acid increased hair counts compared with placebo, with no reported adverse events. The peptide was GHK without copper, and another active ingredient accompanied it.

That makes the formulation interesting on its own terms. Giving GHK-Cu alone credit for the hair result would erase both the copper distinction and the companion ingredient. The tested mixture seems interesting enough in its own right.

GHK-Cu tolerability

Community accounts describe firmer-feeling skin, softer-looking lines and improved hydration. Other accounts describe redness, itching, dryness, breakouts or uneven pigmentation. These are anecdotal accounts, not clinical evidence; the impressions cannot establish the ingredient’s effect or the frequency of a reaction.

Copper Tripeptide-1 has a cosmetic history, while GHK-Cu has no FDA-approved treatment indication. Injectable and systemic uses remain unapproved and lack validated human pharmacokinetic data. Theoretical concerns include copper accumulation with prolonged systemic exposure and oxidation if copper becomes detached from the peptide. Human copper-toxicity harm attributable to GHK-Cu has not been established.

The small topical-study literature and its delivery limitations leave me with specific skin questions to follow. Claims about rejuvenating the whole body ask for much more.